227 related articles for article (PubMed ID: 17438169)
21. Late postpancreatectomy hemorrhage after pancreaticoduodenectomy: is it possible to recognize risk factors?
Ricci C; Casadei R; Buscemi S; Minni F
JOP; 2012 Mar; 13(2):193-8. PubMed ID: 22406600
[TBL] [Abstract][Full Text] [Related]
22. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
[TBL] [Abstract][Full Text] [Related]
23. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
Gullo L; Migliori M; Falconi M; Pederzoli P; Bettini R; Casadei R; Delle Fave G; Corleto VD; Ceccarelli C; Santini D; Tomassetti P
Am J Gastroenterol; 2003 Nov; 98(11):2435-9. PubMed ID: 14638345
[TBL] [Abstract][Full Text] [Related]
24. Parenchyma-sparing resections for pancreatic neuroendocrine tumors.
Cherif R; Gaujoux S; Couvelard A; Dokmak S; Vuillerme MP; Ruszniewski P; Belghiti J; Sauvanet A
J Gastrointest Surg; 2012 Nov; 16(11):2045-55. PubMed ID: 22911124
[TBL] [Abstract][Full Text] [Related]
25. Surgery for mucin-producing pancreatic tumor.
Yasuda H; Takada T; Amano H; Yoshida M
Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
[TBL] [Abstract][Full Text] [Related]
26. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
Schurr PG; Strate T; Rese K; Kaifi JT; Reichelt U; Petri S; Kleinhans H; Yekebas EF; Izbicki JR
Ann Surg; 2007 Feb; 245(2):273-81. PubMed ID: 17245182
[TBL] [Abstract][Full Text] [Related]
27. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
29. Transgastric pancreaticogastric anastomosis: an alternative operative approach for middle pancreatectomy.
LaFemina J; Vagefi PA; Warshaw AL; Fernández-del Castillo C
Arch Surg; 2010 May; 145(5):476-81. PubMed ID: 20479347
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
31. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
32. Resection strategies for neuroendocrine pancreatic neoplasms.
Watzka FM; Laumen C; Fottner C; Weber MM; Schad A; Lang H; Musholt TJ
Langenbecks Arch Surg; 2013 Mar; 398(3):431-40. PubMed ID: 23143147
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of nonfunctioning islet cell tumor: report of 41 cases.
Guo KJ; Liao HH; Tian YL; Guo RX; He SG; Shen K
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):469-72. PubMed ID: 15313691
[TBL] [Abstract][Full Text] [Related]
34. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.
Sellner F; Thalhammer S; Stättner S; Karner J; Klimpfinger M
J Surg Oncol; 2011 Jul; 104(1):17-21. PubMed ID: 21360536
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits.
Fernández-Cruz L; Herrera M; Sáenz A; Pantoja JP; Astudillo E; Sierra M
Best Pract Res Clin Endocrinol Metab; 2001 Jun; 15(2):161-75. PubMed ID: 11472032
[TBL] [Abstract][Full Text] [Related]
36. [Minimally invasive resection of neuroendocrine pancreatic tumors].
Langer P; Fendrich V; Bartsch DK
Chirurg; 2009 Feb; 80(2):105-12. PubMed ID: 19099267
[TBL] [Abstract][Full Text] [Related]
37. Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience.
Bonney GK; Gomez D; Rahman SH; Verbeke CS; Prasad KR; Toogood GJ; Lodge JP; Menon KV
JOP; 2008 Jan; 9(1):19-25. PubMed ID: 18182738
[TBL] [Abstract][Full Text] [Related]
38. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
39. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
40. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
